tirzepatide versus semaglutide vs. Semaglutide: Which Works Best? Subcutaneously administered tirzepatide vs semaglutide

Semaglutide is unlikely to cause liver damage and may even reduce liver fat, though it's not a treatment for liver conditions

Watch for new or worsening depression, suicidal thoughts, or unusual behavioral mood changes

Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials

These compounds collectively provide researchers with tools for investigating incretin receptor biology, metabolic signaling integration, and endocrine pathway regulation

V, Opaleye-Enakhimion, T., Udeogu, J

Great as a secondary pouch or for short-distance travel